André Guimarães

Dr. André Guimarães

Universidade Federal do Rio de Janeiro, Faculdade de Farmácia
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
CFClaudia pinto Figueiredo
Claudia pinto Figueiredo
FBFernanda G. Q. Barros-Aragão
Fernanda G. Q. Barros-Aragão
RNRomulo Leao Silva Neris
Romulo Leao Silva Neris
PFPaula S. Frost
Paula S. Frost
CSCarolina Soares
Carolina Soares
SFSergio T. Ferreira
Sergio T. Ferreira
Neurological complications affecting the central nervous system have been reported in adult patients infected by Zika virus (ZIKV) but the underlying mechanisms remain unknown. Here, we report that ZIKV replicates in human and mouse adult brain tissue, targeting mature neurons. ZIKV preferentially targets memory-related brain regions, inhibits hippocampal long-term potentiation and induces memory impairment in adult mice. TNF-α upregulation, microgliosis and upregulation of complement system proteins, C1q and C3, are induced by ZIKV infection. Microglia are found to engulf hippocampal presynaptic terminals during acute infection. Neutralization of TNF-α signaling, blockage of microglial activation or of C1q/C3 prevent synapse and memory impairment in ZIKV-infected mice. Results suggest that ZIKV induces synapse and memory dysfunction via aberrant activation of TNF-α, microglia and complement. Our findings establish a mechanism by which ZIKV affects the adult brain, and point to the need of evaluating cognitive deficits as a potential comorbidity in ZIKV-infected adults.

1 March 2013 in Flora
Verified
Journal Article
Closed access
André GuimarãesAndré Guimarães
André Guimarães
CBCarlos Henrique Brasil Bizarri
Carlos Henrique Brasil Bizarri
LBLeandro Silva Barbosa
Leandro Silva Barbosa
MNMarcos Jun Nakamura
Marcos Jun Nakamura
MRMônica Freiman de Souza Ramos
Mônica Freiman de Souza Ramos
AVAna Cláudia de Macêdo Vieira
Ana Cláudia de Macêdo Vieira


14 August 2014 in Plant Biology
Verified
Journal Article
Closed access
PDF file
André GuimarãesAndré Guimarães
André Guimarães
PNP. M. Neufeld
P. M. Neufeld
LSL. D. R. Santiago‐Fernandes
L. D. R. Santiago‐Fernandes
AVA. C. M. Vieira
A. C. M. Vieira

17 May 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
AMAmanda de Oliveira Esteves Moreira
Amanda de Oliveira Esteves Moreira
LNLêda Maria Santana Azevedo Neta
Lêda Maria Santana Azevedo Neta
MPMarcia Pietroluongo
Marcia Pietroluongo
AMAna Paula dos Santos Matos
Ana Paula dos Santos Matos
BCBeatriz B. Correa
Beatriz B. Correa
LCLucio Cabral
Lucio Cabral
Background/Objectives: Pediatric drug administration is hindered by difficulties in swallowing conventional medications and the unpalatable taste of many drugs. Among diseases highlighting the need for improved pediatric delivery, tuberculosis (TB) stands out. One form of the disease is latent TB infection (LTBI), which is concerning in children. Effective LTBI treatment is crucial for prevention, with isoniazid (INH) widely used for its proven efficacy and safety. This study aims to develop innovative 3D-printed chewable gels containing INH for LTBI treatment. Methods: The gels were formulated using gelatin and carrageenan gum, sugar-free sweeteners, and flavoring. Two batches were prepared, and using 3D printing (3DP) with a semi-solid extrusion (SSE) module, chewable gels were produced. Rheological properties were measured to assess the feasibility of 3DP-SSE, evaluating the structural integrity and adequate fluidity of the formulation. The 3D-printed chewable gels were evaluated by visual, mass, and dimensional characteristics. In addition, the water activity, texture profile, INH and degradation product content, in vitro release, and taste-masking were investigated. Results: The optimized formulation maintained suitable rheological properties for 3DP-SSE, demonstrating consistent weight, dimensions, and stability after the process. The texture achieved a balance between printing parameters and shape maintenance, and the INH presented an immediate-release profile (>85% within 30 min). The chewable gels showed an improvement in palatability compared to conventional INH tablets. Conclusions: This innovative approach offers a promising solution for pediatric LTBI treatment, as it improves efficacy, medication acceptability, and on-demand access.

31 July 2013 in Revista Agrogeoambiental
Verified
Journal Article
Open access
PDF file
KRKarine Da Silva Ribeiro
Karine Da Silva Ribeiro
André GuimarãesAndré Guimarães
André Guimarães
A prática de utilizar elementos da natureza com finalidade de auxiliar o homem já é bastante antiga. Desde os tempos primitivos, plantas, animais e elementos químicos fazem parte dos “medicamentos” que o homem utiliza. Com o passar do tempo, baseado no conhecimento do homem, surgiram pesquisas a fim de verificar o potencial de certas plantas, a partir daí surgiram os fármacos compostos de matéria prima vegetal, pois surgiram do isolamento de alguns extratos vegetais. O objetivo deste trabalho é fazer um levantamento de dados a fim de obtermos informações sobre a prescrição de tratamentos à base de plantas medicinais e fitoterápicos por médicos do SUS (Sistema Único de Saúde), do município de Teresópolis, RJ. Foram entrevistados 18 médicos de diferentes especialidades, do ambulatório do UNIFESO. Do total de entrevistados, 83,3%, afirmou acreditar no potencial dos medicamentos à base de plantas medicinais e apoia o uso destes medicamentos, mas a maioria, 94,4%, diz não conhecer o programa, que é exatamente o que regulamenta o uso de plantas medicinais, e possui um “banco de dados” das plantas que tem sua “confiabilidade” verificada. O fato de a maioria dos médicos não terem conhecimento sobre o programa nacional de plantas medicinais, é algo preocupante, pois foi possível perceber na realização desta pesquisa, que alguns consideram o uso de plantas, ou de medicamentos à base de plantas medicinais uma forma de tratamento com menos efeitos colaterais, porém esta falta de informação sobre o programa não garante uma relação risco-benefício favorável. Assim, é de total importância que médicos formados e acadêmicos conheçam o programa nacional de plantas medicinais para uma possível implantação de programas que incentivem o de tratamentos à base de plantas medicinais pelo SUS como uma alternativa mais viável.